9-[7-(4-dibenzofuran-2-yl-6-phenyl-1,3,5-triazin-2-yl)dibenzofuran-3-yl]pyrido[2,3-b]indole
C44H25N5O2 — CID 156577807
Data last refreshed: (MolForge compound catalog, from PubChem)
About 9-[7-(4-dibenzofuran-2-yl-6-phenyl-1,3,5-triazin-2-yl)dibenzofuran-3-yl]pyrido[2,3-b]indole
9-[7-(4-dibenzofuran-2-yl-6-phenyl-1,3,5-triazin-2-yl)dibenzofuran-3-yl]pyrido[2,3-b]indole (PubChem CID 156577807) has the molecular formula C44H25N5O2 and a molecular weight of 655.72 g/mol. Its IUPAC name is 9-[7-(4-dibenzofuran-2-yl-6-phenyl-1,3,5-triazin-2-yl)dibenzofuran-3-yl]pyrido[2,3-b]indole.
Molecular Properties
| Compound Name | 9-[7-(4-dibenzofuran-2-yl-6-phenyl-1,3,5-triazin-2-yl)dibenzofuran-3-yl]pyrido[2,3-b]indole |
|---|---|
| PubChem CID | 156577807 |
| Molecular Formula | C44H25N5O2 |
| Molecular Weight | 655.72 g/mol |
| Exact Mass | 655.20 |
| IUPAC Name | 9-[7-(4-dibenzofuran-2-yl-6-phenyl-1,3,5-triazin-2-yl)dibenzofuran-3-yl]pyrido[2,3-b]indole |
| SMILES | c1ccc(-c2nc(-c3ccc4c(c3)oc3cc(-n5c6ccccc6c6cccnc65)ccc34)nc(-c3ccc4oc5ccccc5c4c3)n2)cc1 |
| InChI | InChI=1S/C44H25N5O2/c1-2-9-26(10-3-1)41-46-42(27-17-21-38-35(23-27)31-12-5-7-15-37(31)50-38)48-43(47-41)28-16-19-32-33-20-18-29(25-40(33)51-39(32)24-28)49-36-14-6-4-11-30(36)34-13-8-22-45-44(34)49/h1-25H |
| InChIKey | BRSWVOQLGGRQBX-UHFFFAOYSA-N |
| XLogP | 11.16 |
| TPSA | 82.77 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 51 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 655.72 |
| LogP ≤ 5 | 11.16 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 156577807 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.